Migrating potential patient safety risk: Omeprazole 40mg and Flecainide 100mg capsules
Submission to Pharmaceutical Society of New Zealand, 20 March 2025
Submission to Pharmaceutical Society of New Zealand, 20 March 2025
Submission to Medsafe
View resource
Submission to Office of the Privacy Commissioner
View resource
Submission to Office of the Privacy Commissioner
View resource